Welcome to our dedicated page for Trilogy AI news (Ticker: TRAIF), a resource for investors and traders seeking the latest updates and insights on Trilogy AI stock.
Trilogy AI Corp (TRAIF) delivers cutting-edge artificial intelligence solutions for the beauty technology sector through its proprietary Scarlett platform. This news hub provides investors and industry observers with essential updates about the company’s strategic initiatives, financial developments, and technological advancements.
Access real-time updates on TRAIF’s licensing agreements, subscription model expansions, and capital structure changes including its recent share consolidation. Our curated news collection covers earnings reports, leadership appointments, and partnership announcements that shape the company’s position in AI-driven beauty innovation.
Key focus areas include AI software enhancements, market strategy shifts, and financial performance metrics. Bookmark this page for streamlined access to verified information about Trilogy AI Corp’s unique integration of quantitative trading expertise with beauty tech solutions.
Tokenwell Platforms Inc. (CSE: TWEL) has appointed Abraham Theodore as its new Chief Operating Officer (Product), effective August 12, 2025. Theodore joins from NDAX, one of Canada's major cryptocurrency exchanges, where he served as Head of Product.
Theodore brings 19 years of experience in product management and strategic growth, including previous roles at IBM and Citi. At Tokenwell, he will lead the vision and execution of the company's crypto index portfolio platform targeting both retail and institutional investors globally.
Tokenwell Platforms Inc. (TRAIF), formerly known as Trilogy AI Corp., has announced the grant of 2,025,000 stock options to its directors, officers, and consultants. The options are exercisable at $0.35 per share with a three-year expiration period. The vesting schedule is structured as 25% every six months from the award date.
Of the total grant, Mr. Burgess received 1,300,000 stock options. Additionally, the Board has authorized Mr. Burgess to approve up to 1,150,000 additional stock options for future employee and consultant retention purposes.
Trilogy AI Corp (CSE: TRAI) (OTCQB: TRAIF) announces multiple concurrent offerings: (i) a LIFE Offering of up to 7M common shares at C$0.07 per share for C$490,000, (ii) a Private Placement of up to 5M shares at C$0.07 for C$350,000, and (iii) a Warrant Offering of up to 12M warrants at C$0.05 each for C$600,000. LIFE Offering purchasers must buy 0.714 Private Placement shares for each LIFE share. Warrants are exercisable at C$0.05 for 24 months, subject to shareholder approval. The offerings are expected to close around December 23, 2024. Proceeds will be used for working capital and general corporate purposes.
Trilogy AI Corp. (CSE: TRAI) has announced a share consolidation effective December 6, 2024. The consolidation will be conducted on a 4:1 basis, meaning one post-consolidated share will replace every four pre-consolidated shares. Following the consolidation, approximately 14,132,204 shares will be outstanding, subject to rounding adjustments. No fractional shares will be issued. The company's trading symbol remains 'TRAI', though a new CUSIP number (895979201) has been assigned. The transfer agent, Odyssey Trust Company, confirmed that shareholders of record will hold shares represented by a DRS statement, with the consolidation being conducted on a 'push-out' basis.
Trilogy AI Corp (CSE: TRAI) (OTCQB: TRAIF) has announced a 4:1 share consolidation, which will reduce its outstanding shares from 56,528,815 to approximately 14,132,204. The Board believes this consolidation will enhance financing opportunities and improve trading liquidity. Additionally, the company has appointed DJ Bowen as a Director, bringing over 20 years of expertise in quantitative trading, portfolio management, and financial software development.
FAQ
What is the current stock price of Trilogy AI (TRAIF)?
What is the market cap of Trilogy AI (TRAIF)?
